InpharmD™ helps healthcare providers make better clinical decisions by giving them the data behind their questions.
- Founded: 2018
- Funding stage: Seed ($6.05M)
- Revenue stage: Series A ($2-5M annual run rate)
- Net gain/loss per month: profitable
What makes us different is that we've grown fast while being capital efficient (not raising much money). We've done this with a performance-driven culture that attracts, retains, and rewards phenomenal people. We also:
- Leverage scale - We focus on processes and systems necessary for us to grow intentionally today and into the future.
- Share an ownership (driver vs passenger) mindset - We iterate at a remarkable pace amidst uncertainty, putting in long hours along the way - but because we love it.
- Avoid drama and wasted time - None of us want a political company culture and we meet once a week (formally).
Market conditions are perfect for us to continue to grow at this pace with a small and mighty team. This is our competitive advantage over bloated incumbents, and by the time they realize it, it'll be too late.